BMY Bristol Myers Squibb
NYSE · SEC CIK 14272 · EDGAR
- Bought, last 12 months
- $0 0 purchases by 0 insiders
- Sold, last 12 months
- $2.29M 3 sales by 3 insiders
- Filings on record
- 369 since 2021-07-01, latest 2026-09-10 16:37
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| Elkins David V | EVP, CFO | — | $1.85M |
| Massacesi Cristian | EVP, Chief Med Offr, Head of Dev | — | $403.5K |
| Holzer Phil M | SVP, Ctrl | — | $33.8K |
| Short Bartie Wendy | EVP, Corp. Affairs | — | — |
| Hoch Lynelle | Pres, Cell Therapy Org | — | — |
| Poole Ahn Amanda | EVP, CHRO | — | — |
| Gallman Cari | EVP, GC | — | — |
| Lenkowsky Adam | EVP, Chief Commercial Off | — | — |
| Shanahan Karin | EVP, Chief Supply Chain, Ops | — | — |
| Meyers Gregory Scott | EVP, Chief Digital, Tech Off | — | — |
Transactions 333
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-04-04 | 2023-04-01 | BMY | Shanahan Karin | EVP, Glob. Prod. Dev, Supply | F - Tax | $69.31 | -1,692 | 3,226 | -34% | -$117.3K |
| D | 2023-03-14 | 2023-03-10 | BMY | Meyers Gregory Scott | EVP, Chief Digital, Tech Off | J - Other | $0.00 | +92 | 4,740 | +2% | $0 |
| D | 2023-03-14 | 2023-03-10 | BMY | Meyers Gregory Scott | EVP, Chief Digital, Tech Off | M - OptEx | $0.00 | +2,836 | 4,648 | +157% | $0 |
| D | 2023-03-14 | 2023-03-10 | BMY | Meyers Gregory Scott | EVP, Chief Digital, Tech Off | F - Tax | $65.71 | -1,243 | 3,497 | -26% | -$81.7K |
| D | 2023-03-14 | 2023-03-10 | BMY | Weese Michelle | EVP, Corp. Affairs | F - Tax | $65.71 | -594 | 2,250 | -21% | -$39.0K |
| D | 2023-03-14 | 2023-03-10 | BMY | Weese Michelle | EVP, Corp. Affairs | M - OptEx | $0.00 | +1,590 | 2,793 | +132% | $0 |
| D | 2023-03-14 | 2023-03-10 | BMY | Weese Michelle | EVP, Corp. Affairs | J - Other | $0.00 | +51 | 2,844 | +2% | $0 |
| DM | 2023-03-14 | 2023-03-10 | BMY | Powell Ann | EVP, Chief Human Resources | J - Other | $0.00 | +5,174 | 28.1K | +23% | $0 |
| DM | 2023-03-14 | 2023-03-10 | BMY | Powell Ann | EVP, Chief Human Resources | F - Tax | $65.71 | -16.8K | 25.9K | -39% | -$1.10M |
| DM | 2023-03-14 | 2023-03-10 | BMY | Powell Ann | EVP, Chief Human Resources | M - OptEx | $0.00 | +34.4K | 29.4K | New | $0 |
| DM | 2023-03-14 | 2023-03-10 | BMY | LEUNG SANDRA | EVP, GC | M - OptEx | $0.00 | +58.0K | 356.9K | +19% | $0 |
| DM | 2023-03-14 | 2023-03-10 | BMY | LEUNG SANDRA | EVP, GC | F - Tax | $65.71 | -34.1K | 322.2K | -10% | -$2.24M |
| DM | 2023-03-14 | 2023-03-10 | BMY | LEUNG SANDRA | EVP, GC | J - Other | $0.00 | +8,731 | 317.2K | +3% | $0 |
| DM | 2023-03-14 | 2023-03-10 | BMY | Caforio Giovanni | CEO, Board COB, Dir | M - OptEx | $0.00 | +234.7K | 301.9K | +349% | $0 |
| DM | 2023-03-14 | 2023-03-10 | BMY | Caforio Giovanni | CEO, Board COB, Dir | F - Tax | $65.71 | -138.0K | 290.9K | -32% | -$9.07M |
| DM | 2023-03-14 | 2023-03-10 | BMY | Caforio Giovanni | CEO, Board COB, Dir | J - Other | $0.00 | +35.1K | 302.7K | +13% | $0 |
| DM | 2023-03-14 | 2023-03-10 | BMY | VESSEY RUPERT | EVP, Pres, Research | J - Other | $0.00 | +8,326 | 123.7K | +7% | $0 |
| DM | 2023-03-14 | 2023-03-10 | BMY | VESSEY RUPERT | EVP, Pres, Research | M - OptEx | $0.00 | +66.9K | 118.3K | +130% | $0 |
| DM | 2023-03-14 | 2023-03-10 | BMY | VESSEY RUPERT | EVP, Pres, Research | F - Tax | $65.71 | -38.5K | 73.7K | -34% | -$2.53M |
| DM | 2023-03-14 | 2023-03-10 | BMY | Mily Elizabeth | EVP, Strategy, BD | M - OptEx | $0.00 | +29.6K | 17.7K | New | $0 |
| DM | 2023-03-14 | 2023-03-10 | BMY | Mily Elizabeth | EVP, Strategy, BD | F - Tax | $65.71 | -14.0K | 14.0K | -50% | -$922.6K |
| DM | 2023-03-14 | 2023-03-10 | BMY | Mily Elizabeth | EVP, Strategy, BD | J - Other | $0.00 | +3,458 | 16.0K | +28% | $0 |
| DM | 2023-03-14 | 2023-03-10 | BMY | BOERNER CHRISTOPHER S. | EVP, Chief Commercial Off | J - Other | $0.00 | +8,568 | 96.1K | +10% | $0 |
| DM | 2023-03-14 | 2023-03-10 | BMY | BOERNER CHRISTOPHER S. | EVP, Chief Commercial Off | M - OptEx | $0.00 | +59.1K | 60.7K | +3,697% | $0 |
| DM | 2023-03-14 | 2023-03-10 | BMY | BOERNER CHRISTOPHER S. | EVP, Chief Commercial Off | F - Tax | $65.71 | -34.6K | 54.1K | -39% | -$2.27M |
| D | 2023-03-14 | 2023-03-10 | BMY | Shanahan Karin | EVP, Glob. Prod. Dev, Supply | M - OptEx | $0.00 | +2,447 | 2,447 | New | $0 |
| D | 2023-03-14 | 2023-03-10 | BMY | Shanahan Karin | EVP, Glob. Prod. Dev, Supply | F - Tax | $65.71 | -914 | 1,612 | -36% | -$60.1K |
| D | 2023-03-14 | 2023-03-10 | BMY | Shanahan Karin | EVP, Glob. Prod. Dev, Supply | J - Other | $0.00 | +79 | 2,526 | +3% | $0 |
| DM | 2023-03-14 | 2023-03-10 | BMY | Elkins David V | EVP, CFO | J - Other | $0.00 | +8,930 | 141.2K | +7% | $0 |
| DM | 2023-03-14 | 2023-03-10 | BMY | Elkins David V | EVP, CFO | F - Tax | $65.71 | -41.3K | 137.2K | -23% | -$2.72M |
| DM | 2023-03-14 | 2023-03-10 | BMY | Elkins David V | EVP, CFO | M - OptEx | $0.00 | +71.9K | 140.9K | +104% | $0 |
| DM | 2023-03-14 | 2023-03-10 | BMY | Hirawat Samit | EVP, Chief Med.Offr, Drug Dev | F - Tax | $65.71 | -22.4K | 28.9K | -44% | -$1.47M |
| DM | 2023-03-14 | 2023-03-10 | BMY | Hirawat Samit | EVP, Chief Med.Offr, Drug Dev | M - OptEx | $0.00 | +39.0K | 25.5K | New | $0 |
| DM | 2023-03-14 | 2023-03-10 | BMY | Hirawat Samit | EVP, Chief Med.Offr, Drug Dev | J - Other | $0.00 | +4,800 | 29.4K | +20% | $0 |
| 2023-02-08 | 2023-02-06 | BMY | Powell Ann | EVP, Chief Human Resources | S - Sale | $74.69 | -11.2K | 23.0K | -33% | -$835.3K | |
| 2023-02-08 | 2023-02-06 | BMY | Caforio Giovanni | CEO, Board COB, Dir | S - Sale | $74.65 | -240.0K | 236.1K | -50% | -$17.92M | |
| D | 2023-02-03 | 2023-02-01 | BMY | Meyers Gregory Scott | EVP, Chief Digital, Tech Off | F - Tax | $71.23 | -731 | 1,812 | -29% | -$52.1K |
| D | 2023-02-03 | 2023-02-01 | BMY | Meyers Gregory Scott | EVP, Chief Digital, Tech Off | M - OptEx | $0.00 | +2,543 | 2,543 | New | $0 |
| D | 2022-12-06 | 2022-12-02 | BMY | Elkins David V | EVP, CFO | M - OptEx | $0.00 | +8,792 | 128.6K | +7% | $0 |
| D | 2022-12-06 | 2022-12-02 | BMY | Elkins David V | EVP, CFO | F - Tax | $81.13 | -4,498 | 124.1K | -3% | -$364.9K |
| D | 2022-12-06 | 2022-12-02 | BMY | VESSEY RUPERT | EVP, Research, Early Dev | F - Tax | $81.13 | -4,498 | 61.4K | -7% | -$364.9K |
| D | 2022-12-06 | 2022-12-02 | BMY | VESSEY RUPERT | EVP, Research, Early Dev | M - OptEx | $0.00 | +8,792 | 65.9K | +15% | $0 |
| D | 2022-12-06 | 2022-12-02 | BMY | BOERNER CHRISTOPHER S. | EVP, Chief Commercial Off | F - Tax | $81.13 | -1,349 | 43.3K | -3% | -$109.4K |
| D | 2022-12-06 | 2022-12-02 | BMY | BOERNER CHRISTOPHER S. | EVP, Chief Commercial Off | M - OptEx | $0.00 | +2,637 | 44.6K | +6% | $0 |
| 2022-11-14 | 2022-11-09 | BMY | Powell Ann | EVP, Chief Human Resources | S - Sale | $80.45 | -16.2K | 34.2K | -32% | -$1.31M | |
| DM | 2022-11-09 | 2022-11-07 | BMY | VESSEY RUPERT | EVP, Research, Early Dev | M - OptEx | $58.31 | +52.6K | 77.5K | +211% | +$3.07M |
| D | 2022-11-09 | 2022-11-07 | BMY | VESSEY RUPERT | EVP, Research, Early Dev | S - Sale+OE | $78.88 | -45.9K | 57.1K | -45% | -$3.62M |
| 2022-09-22 | 2022-09-20 | BMY | Caforio Giovanni | CEO, Board COB, Dir | S - Sale | $69.71 | -25.0K | 476.1K | -5% | -$1.74M | |
| 2022-09-16 | 2022-09-15 | BMY | Caforio Giovanni | CEO, Board COB, Dir | S - Sale | $71.84 | -50.0K | 501.1K | -9% | -$3.59M | |
| DM | 2022-09-15 | 2022-09-13 | BMY | Elkins David V | EVP, CFO | M - OptEx | $48.49 | +123.3K | 102.5K | New | +$5.98M |
| DM | 2022-09-15 | 2022-09-13 | BMY | Elkins David V | EVP, CFO | S - Sale+OE | $71.30 | -134.0K | 100.5K | -57% | -$9.55M |
| 2022-09-15 | 2022-09-14 | BMY | Powell Ann | EVP, Chief Human Resources | S - Sale | $70.75 | -25.0K | 50.5K | -33% | -$1.77M | |
| D | 2022-07-05 | 2022-07-01 | BMY | Hirawat Samit | EVP, Chief Med.Offr, Drug Dev | M - OptEx | $0.00 | +9,356 | 26.1K | +56% | $0 |
| D | 2022-07-05 | 2022-07-01 | BMY | Hirawat Samit | EVP, Chief Med.Offr, Drug Dev | F - Tax | $76.84 | -4,786 | 21.3K | -18% | -$367.8K |
| D | 2022-07-05 | 2022-07-01 | BMY | Weese Michelle | EVP, Corp. Affairs | M - OptEx | $0.00 | +1,885 | 1,885 | New | $0 |
| D | 2022-07-05 | 2022-07-01 | BMY | Weese Michelle | EVP, Corp. Affairs | F - Tax | $76.84 | -682 | 1,203 | -36% | -$52.4K |
| 2022-06-14 | 2022-06-13 | BMY | Caforio Giovanni | CEO, Board COB, Dir | S - Sale | $74.04 | -30.0K | 551.1K | -5% | -$2.22M | |
| D | 2022-06-07 | 2022-06-03 | BMY | Haller Julia A | Dir | M - OptEx | $0.00 | +2,949 | 13.6K | +28% | $0 |
| 2022-06-07 | 2022-06-06 | BMY | LEUNG SANDRA | EVP, GC | S - Sale | $74.89 | -65.0K | 308.6K | -17% | -$4.87M | |
| DM | 2022-04-04 | 2022-04-01 | BMY | Mily Elizabeth | EVP, Strategy, BD | M - OptEx | $0.00 | +6,347 | 12.5K | +103% | $0 |
| D | 2022-04-04 | 2022-04-01 | BMY | Mily Elizabeth | EVP, Strategy, BD | J - Other | $0.00 | +1,508 | 12.0K | +14% | $0 |
| DM | 2022-04-04 | 2022-04-01 | BMY | Mily Elizabeth | EVP, Strategy, BD | F - Tax | $73.82 | -3,333 | 9,796 | -25% | -$246.0K |
| 2022-03-23 | 2022-03-21 | BMY | Caforio Giovanni | CEO, Board COB, Dir | S - Sale | $71.52 | -25.0K | 581.5K | -4% | -$1.79M | |
| 2022-03-23 | 2022-03-22 | BMY | Caforio Giovanni | CEO, Board COB, Dir | G - Gift | $0.00 | -420 | 581.1K | -0.1% | $0 | |
| DM | 2022-03-18 | 2022-03-16 | BMY | VESSEY RUPERT | EVP, Research, Early Dev | M - OptEx | $57.00 | +47.3K | 72.9K | +185% | +$2.70M |
| DM | 2022-03-18 | 2022-03-16 | BMY | VESSEY RUPERT | EVP, Research, Early Dev | S - Sale+OE | $69.25 | -74.6K | 46.3K | -62% | -$5.16M |
| 2022-03-16 | 2022-03-14 | BMY | Santiago Karen Murphy | SVP, Ctrl | S - Sale | $69.20 | -6,577 | 16.7K | -28% | -$455.1K | |
| 2022-03-16 | 2022-03-14 | BMY | BOERNER CHRISTOPHER S. | EVP, Chief Commercial Off | S - Sale | $69.20 | -29.5K | 42.0K | -41% | -$2.04M | |
| DM | 2022-03-14 | 2022-03-10 | BMY | Caforio Giovanni | CEO, Board COB, Dir | M - OptEx | $0.00 | +239.5K | 502.0K | +91% | $0 |
| DM | 2022-03-14 | 2022-03-10 | BMY | Caforio Giovanni | CEO, Board COB, Dir | J - Other | $0.00 | +72.5K | 495.1K | +17% | $0 |
| DM | 2022-03-14 | 2022-03-10 | BMY | Caforio Giovanni | CEO, Board COB, Dir | F - Tax | $68.42 | -158.9K | 478.6K | -25% | -$10.87M |
| DM | 2022-03-14 | 2022-03-10 | BMY | VESSEY RUPERT | EVP, Research, Early Dev | J - Other | $0.00 | +1,859 | 82.1K | +2% | $0 |
| DM | 2022-03-14 | 2022-03-10 | BMY | VESSEY RUPERT | EVP, Research, Early Dev | M - OptEx | $0.00 | +15.2K | 81.2K | +23% | $0 |
| DM | 2022-03-14 | 2022-03-10 | BMY | VESSEY RUPERT | EVP, Research, Early Dev | F - Tax | $68.42 | -8,751 | 77.6K | -10% | -$598.7K |
| DM | 2022-03-14 | 2022-03-10 | BMY | LEUNG SANDRA | EVP, GC | M - OptEx | $0.00 | +60.3K | 388.7K | +18% | $0 |
| DM | 2022-03-14 | 2022-03-10 | BMY | LEUNG SANDRA | EVP, GC | J - Other | $0.00 | +18.3K | 403.6K | +5% | $0 |
| DM | 2022-03-14 | 2022-03-10 | BMY | LEUNG SANDRA | EVP, GC | F - Tax | $68.42 | -44.9K | 373.6K | -11% | -$3.07M |
| DM | 2022-03-14 | 2022-03-10 | BMY | Elkins David V | EVP, CFO | M - OptEx | $0.00 | +16.1K | 134.1K | +14% | $0 |
| DM | 2022-03-14 | 2022-03-10 | BMY | Elkins David V | EVP, CFO | J - Other | $0.00 | +1,962 | 135.0K | +1% | $0 |
| DM | 2022-03-14 | 2022-03-10 | BMY | Elkins David V | EVP, CFO | F - Tax | $68.42 | -9,222 | 126.1K | -7% | -$631.0K |
| DM | 2022-03-14 | 2022-03-10 | BMY | Hirawat Samit | EVP, Chief Med.Offr, Drug Dev | F - Tax | $68.42 | -5,205 | 14.1K | -27% | -$356.1K |
| DM | 2022-03-14 | 2022-03-10 | BMY | Hirawat Samit | EVP, Chief Med.Offr, Drug Dev | J - Other | $0.00 | +1,101 | 16.5K | +7% | $0 |
| DM | 2022-03-14 | 2022-03-10 | BMY | Hirawat Samit | EVP, Chief Med.Offr, Drug Dev | M - OptEx | $0.00 | +9,074 | 15.9K | +132% | $0 |
| DM | 2022-03-14 | 2022-03-10 | BMY | Powell Ann | EVP, Chief Human Resources | J - Other | $0.00 | +12.5K | 56.0K | +29% | $0 |
| DM | 2022-03-14 | 2022-03-10 | BMY | Powell Ann | EVP, Chief Human Resources | M - OptEx | $0.00 | +35.7K | 55.5K | +180% | $0 |
| DM | 2022-03-14 | 2022-03-10 | BMY | Powell Ann | EVP, Chief Human Resources | F - Tax | $68.42 | -20.4K | 54.3K | -27% | -$1.39M |
| DM | 2022-03-14 | 2022-03-10 | BMY | BOERNER CHRISTOPHER S. | EVP, Chief Commercial Off | A - Grant | $0.00 | +13.4K | 94.3K | +17% | $0 |
| DM | 2022-03-14 | 2022-03-10 | BMY | BOERNER CHRISTOPHER S. | EVP, Chief Commercial Off | M - OptEx | $0.00 | +51.7K | 48.5K | New | $0 |
| DM | 2022-03-14 | 2022-03-10 | BMY | BOERNER CHRISTOPHER S. | EVP, Chief Commercial Off | F - Tax | $68.42 | -34.5K | 49.7K | -41% | -$2.36M |
| DM | 2022-03-14 | 2022-03-10 | BMY | BOERNER CHRISTOPHER S. | EVP, Chief Commercial Off | J - Other | $0.00 | +2,399 | 49.3K | +5% | $0 |
| D | 2022-03-14 | 2022-03-10 | BMY | Mily Elizabeth | EVP, Strategy, BD | M - OptEx | $0.00 | +4,005 | 8,246 | +94% | $0 |
| D | 2022-03-14 | 2022-03-10 | BMY | Mily Elizabeth | EVP, Strategy, BD | F - Tax | $68.42 | -1,875 | 6,820 | -22% | -$128.3K |
| D | 2022-03-14 | 2022-03-10 | BMY | Mily Elizabeth | EVP, Strategy, BD | J - Other | $0.00 | +449 | 8,695 | +5% | $0 |
| DM | 2022-03-14 | 2022-03-10 | BMY | Santiago Karen Murphy | SVP, Ctrl | M - OptEx | $0.00 | +11.1K | 17.9K | +163% | $0 |
| DM | 2022-03-14 | 2022-03-10 | BMY | Santiago Karen Murphy | SVP, Ctrl | J - Other | $0.00 | +3,933 | 17.2K | +30% | $0 |
| DM | 2022-03-14 | 2022-03-10 | BMY | Santiago Karen Murphy | SVP, Ctrl | F - Tax | $68.42 | -6,223 | 16.7K | -27% | -$425.8K |
| D | 2022-03-03 | 2022-03-01 | BMY | Elkins David V | EVP, CFO | F - Tax | $68.63 | -10.4K | 121.7K | -8% | -$712.4K |
| D | 2022-03-03 | 2022-03-01 | BMY | Elkins David V | EVP, CFO | M - OptEx | $0.00 | +24.6K | 132.0K | +23% | $0 |
| D | 2022-03-03 | 2022-03-01 | BMY | VESSEY RUPERT | EVP, Research, Early Dev | M - OptEx | $0.00 | +23.4K | 79.6K | +42% | $0 |
| D | 2022-03-03 | 2022-03-01 | BMY | VESSEY RUPERT | EVP, Research, Early Dev | F - Tax | $68.63 | -10.3K | 69.3K | -13% | -$707.1K |
Purchase Sale Sale after option exercise All abbreviations